This product is not supplied for human or veterinary consumption, treatment, diagnosis, prevention, or personal use
Injectable GLP-1 doses are still better studied for weight loss, but the approved 25 mg oral dose produced double-digit weight loss in trials
Adequate levels of B12 can support memory, concentration, and cognitive function
TIER 1 (5mg total) $235 total for an 8 week supply Monthly cost breakdown: $118 based on weekly dose Recommended if new to treatment or for those on 0.2-0.6mg/week TIER 2 (10mg total) $265 total for an 8 week supply Monthly cost breakdown: $133 based on weekly dose Recommended for those on 0.7-1.2mg/week TIER 3 (25mg total) $395 total for an 8 week supply Monthly cost breakdown: $198 based on weekly dose Recommended for those on 1.3mg/week and up OptioRX Pharmacy - Semaglutide/Niacinamide Injection Up to 90 days BUD
T.Prez-SanchezG.Becerril-VillanuevaE.Alvarez-HerreraS.Mendieta-CabreraD.et al
Professor Jastreboffs research contributions include: Principal investigator for GLP3 phase 2 obesity trial demonstrating 24.2% weight loss Leadership in clinical research examining triple hormone receptor agonists Extensive investigations of incretin-based therapies for obesity and metabolic disease Pioneering work on combination approaches to weight management Studies examining neurobiological mechanisms underlying obesity pharmacotherapy Her work has helped establish GLP3 as one of the most promising next-generation obesity treatments in clinical development, contributing to the scientific foundation for multi-pathway metabolic interventions